首页> 中文期刊> 《中国继续医学教育》 >输血前不规则抗体筛查在临床安全输血中的意义分析

输血前不规则抗体筛查在临床安全输血中的意义分析

         

摘要

Objective To explore the significance of irregular antibody screening before transfusion in clinical safe blood transfusion.Methods 1 500 serum samples from March 2014 to December 2015 in our hospital were irregular antibody screened using micro-column gel antiglobulin test method.Results There were 27 cases (1.8%) screened out of irregular antibody, including 9 males and 18 females. Identified by antibody specificity, there were 3 cases of anti-C, 11 cases of anti-E, 8 cases of anti-D, 5 cases of anti-M. Conclusion Irregular antibody screening before transfusion is an important measure to prevent hemolytic transfusion reaction, and has signiifcance for clinical safe blood transfusion.%目的:探讨输血前不规则抗体筛查在临床安全输血中的意义。方法运用微柱凝胶抗人球蛋白试验法对本院2014年3月~2015年12月1500份血清样本进行不规则抗体筛查。结果27例(1.8%)筛查出不规则抗体,其中男9例,女18例。经抗体特异性鉴定,抗-C 3例,抗-E 11例,抗-D 8例,抗-M 5例。结论输血前不规则抗体筛查是预防溶血性输血反应的重要措施,对临床安全输血具有重要意义。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号